Zeiss LSM900 Service Maintenance Contract
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) has issued a Sources Sought Notice for a service maintenance contract for its Carl Zeiss LSM900 confocal imaging system. This market research aims to identify capable businesses to provide maintenance and repair services to minimize system downtime. Capability statements are due April 2, 2026, by 13:00 CT.
Purpose and Scope
CBER requires a 12-month service agreement for its heavily utilized Zeiss LSM900 confocal imaging system (s/n 2901000217), located at the White Oak FDA campus in Silver Spring, MD. The system is critical for CBER's research programs. The scope of work, detailed in the Statement of Work (SOW) on pages 2-3 of the notice, includes technical support, preventive maintenance, and unlimited emergency repair services. Services must be performed by Zeiss Factory trained Field Service Representatives, with specific requirements for parts, response times, and on-site support.
Contract Details & Set-Aside
This is a Sources Sought Notice for market research purposes, not a Request for Proposal (RFP) or Solicitation. The anticipated contract type is Firm Fixed Price. The associated NAICS Code is 811210 – Electronic and Precision Equipment Repair and Maintenance, with a Small Business Size Standard of $34 million. While there is no formal set-aside, the notice aims to identify capable small businesses and encourages responses from "Other than small business concerns" as well.
Response Requirements & Deadline
Interested parties must submit capability statements via email to david.kramer@fda.hhs.gov by April 2, 2026, at 13:00 hours (Central Time). Capability statements should follow the "Sources Sought Response Instructions" (pages 9-10 of the document), detailing company overview, product information, and any relevant GSA Schedule or Best in Class (BIC) contract information. This notice is crucial for understanding the government's intent regarding future procurement and specific requirements.
Place of Performance
The services will be performed at the FDA White Oak campus in Silver Spring, MD 20993, United States.
Contact Information
For inquiries, contact David Kramer (primary) at david.kramer@fda.hhs.gov or Nick Sartain (secondary) at nick.sartain@fda.hhs.gov.